Literature DB >> 12482154

Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk.

Vikas R Dharnidharka1, Amir H Tejani, Ping-Leung Ho, William E Harmon.   

Abstract

We have previously documented Caucasian race and cadaver donor source as risk factors for post-transplant lymphoproliferative disorder (PTLD) development in recipients registered in the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). We analyzed data from the Scientific Registry of the United Network of Organ Sharing (UNOS) (from January 1988 to December 1999) to determine risk factors for the development of PTLD in all organ systems and its frequency, and we compared these factors to the risk factors in the most recent NAPRTCS database (1987-2000). In the UNOS database, PTLD was reported in 2365 of 205114 organ-transplant recipients (1.2%). PTLD was reported in 3% or more of all intestinal and thoracic organ recipients, but in less than 1% of other abdominal organ recipients. Recipient age < 18 years, Caucasian race and male gender were independent risk factors [Odds Ratios (OR) 2.81, 2.22 and 1.40, respectively, p = 0.0001], but not cadaver donor source. The combination of all three risk factors increased the OR to 8.78. The occurrence of PTLD showed a significant rise per year for heart-lung, kidney, kidney-pancreas and liver transplants, but decreased significantly for heart transplants (p < 0.001). Similar frequencies of PTLD were found in smaller organ-specific registries of heart, intestine, pediatric liver and pediatric kidney transplants. The PTLD incidence per year and incidence density have increased in recent years. Young Caucasian males are at highest risk for PTLD development among solid-organ-transplant recipients. The incidence of PTLD is increasing.

Entities:  

Mesh:

Year:  2002        PMID: 12482154     DOI: 10.1034/j.1600-6143.2002.21019.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  30 in total

1.  Newborn Screening for Biliary Atresia.

Authors:  Kasper S Wang
Journal:  Pediatrics       Date:  2015-12       Impact factor: 7.124

2.  Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States.

Authors:  Scott C Quinlan; Ruth M Pfeiffer; Lindsay M Morton; Eric A Engels
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

3.  Post-transplant lymphoproliferative disorder in paediatric patients: the Irish perspective-a single centre experience.

Authors:  A Malone; G Kennedy; L Storey; A O'Marcaigh; M McDermott; A M Broderick; O P Smith
Journal:  Ir J Med Sci       Date:  2016-02-29       Impact factor: 1.568

Review 4.  Viral surveillance and subclinical viral infection in pediatric kidney transplantation.

Authors:  Jodi M Smith; Vikas R Dharnidharka
Journal:  Pediatr Nephrol       Date:  2014-08-16       Impact factor: 3.714

5.  Renal transplantation: the present and the future.

Authors:  Vikas R Dharnidharka
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

6.  Malignancies after living-donor and cadaveric lung transplantations in Japanese patients.

Authors:  Satona Tanaka; Toyofumi F Chen-Yoshikawa; Tetsu Yamada; Kyoko Hijiya; Hideki Motoyama; Akihiro Aoyama; Hiroshi Date
Journal:  Surg Today       Date:  2016-03-16       Impact factor: 2.549

Review 7.  The start of the transplant journey: referral for pediatric solid organ transplantation.

Authors:  Diana Shellmer; Cheryl Brosig; Jo Wray
Journal:  Pediatr Transplant       Date:  2014-01-20

8.  Primary brain lymphomas after kidney transplantation: an under-recognized problem?

Authors:  Nuria Sola-Valls; Néstor Yesid Rodríguez C; Carola Arcal; Carlos Duran; Federico Oppenheimer; Teresa Ribalta; Armando Lopez-Guillermo; Josep Marí Campistol; Francesc Graus; Fritz Diekmann
Journal:  J Nephrol       Date:  2014-01-28       Impact factor: 3.902

9.  Immune surveillance and lymphoid malignancy in immunocompromised host.

Authors:  Patrick L Stevens; Nishitha M Reddy
Journal:  Am J Blood Res       Date:  2013-05-05

10.  Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): a Children's Oncology Group Report.

Authors:  T G Gross; M A Orjuela; S L Perkins; J R Park; J C Lynch; M S Cairo; L M Smith; R J Hayashi
Journal:  Am J Transplant       Date:  2012-08-06       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.